Percutaneous closure of left atrial appendage may decrease mortality, hemorrhagic stroke risk

Antithrombotic therapy is consistently recommended for most patients with atrial fibrillation and until recently warfarin, a vitamin K antagonist, has been the antithrombotic of choice.